eCM (European Cells & Materials)

Eur Cell Mater

1473-2262

Therapeutic Area

Biology, Cytology/Cell Biology, Dentistry, Orthopedics, Osteopathy, Surgery, Transplantation, Trauma

Bioengineers, Biomedical Researchers, Cell Biologists, Cytologists, Dentists, Orthopedic Surgeons, Orthopedists, Osteopathic Physicians, Osteopathic Surgeons, Transplant Surgeons, Trauma Surgeons

eCM provides an interdisciplinary forum for publication of preclinical research in the musculoskeletal field (Trauma, Maxillofacial (including dental), Spine and Orthopaedics). Manuscripts must have an important biological dimension, reporting effects at the cellular, tissue or organismic levels. Mechanotransduction papers with musculoskeletal cells are within eCM scope. In vitro cytocompatibilty studies should use primary cells or more than one cell line and provide more than just simple descriptions of cell viability, spreading, proliferation, mineralisation etc. Major improvements with in vitro, ex vivo or in vivo models and relevant opinion papers may be considered. Papers focussing purely on material properties or biomechanics properties (alone or combined, without a strong biological dimension) will not be entertained. Manuscripts on effects of surfaces, coatings, additives etc. in preventing bacterial adhesion must also consider the effect on eukaryotic cells (to be mentioned within the abstract) or refer to previously published data using the exact same surfaces. High level submissions on infection prevention, diagnostics, therapy and major improvement with in vitro or in vivo models within the musculoskeletal field (as defined by eCM below) are within eCM scope.

AOCMF, AOTrauma, European Orthopaedic Research Society (EORS), Scandinavian Society for Biomaterials (ScSB), Swiss Society for Biomaterials and Regenerative Medicine (SSB+RM), Tissue and Cell Engineering Society (TCES)

AO Foundation

Impact Factor Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines